Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AML

Conditions

• Acute Myeloid Leukemia
• Relapsed/Refractory Acute Myeloid Leukemia
• AML, Relapsed/Refractory

Interventions

• PROCEDURE: Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (haplo-HSCT)
• DRUG: Post-transplant Maintenance Therapy

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology